Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Un Jung Kang

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Annals of Neurology|August 2, 2003
Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's diseaseUn Jung Kang, Ken Nakamura
BMC Cell Biology|November 25, 2010
Structural determinants of PINK1 topology and dual subcellular distributionWilliam Lin, Un Jung Kang
Journal of Clinical Neurology (Seoul, Korea)|April 17, 2010
Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic cluesWilliam Lin, Un Jung Kang
Journal of Inherited Metabolic Disease|March 5, 2009
Consideration of gene therapy for paediatric neurotransmitter diseasesMichael Rotstein, Un Jung Kang
Neurology|March 31, 2012
Activity enhances dopaminergic long-duration response in Parkinson diseaseUn Jung Kang, Peggy Auinger,
Journal of Neurochemistry|April 10, 2008
Characterization of PINK1 processing, stability, and subcellular localizationWilliam Lin, Un Jung Kang
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 11, 2014
Reversibility of tardive dyskinesia syndromeAngel Vinuela, Un Jung Kang
Research Square|May 9, 2025
New Diagnostic and Staging Framework Applied to Established PD in the BioFIND CohortMarco J Russo, Un Jung Kang
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Behavioral models of Parkinson's disease in rodents: a new look at an old problemGloria E Meredith, Un Jung Kang
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2015
Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and diseaseMaxime Cazorla, Un Jung Kang, Christoph Kellendonk
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Annals of Neurology|August 2, 2003
Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's diseaseUn Jung Kang, Ken Nakamura
BMC Cell Biology|November 25, 2010
Structural determinants of PINK1 topology and dual subcellular distributionWilliam Lin, Un Jung Kang
Journal of Clinical Neurology (Seoul, Korea)|April 17, 2010
Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic cluesWilliam Lin, Un Jung Kang
Journal of Inherited Metabolic Disease|March 5, 2009
Consideration of gene therapy for paediatric neurotransmitter diseasesMichael Rotstein, Un Jung Kang
Neurology|March 31, 2012
Activity enhances dopaminergic long-duration response in Parkinson diseaseUn Jung Kang, Peggy Auinger,
Journal of Neurochemistry|April 10, 2008
Characterization of PINK1 processing, stability, and subcellular localizationWilliam Lin, Un Jung Kang
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|December 11, 2014
Reversibility of tardive dyskinesia syndromeAngel Vinuela, Un Jung Kang
Research Square|May 9, 2025
New Diagnostic and Staging Framework Applied to Established PD in the BioFIND CohortMarco J Russo, Un Jung Kang
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Behavioral models of Parkinson's disease in rodents: a new look at an old problemGloria E Meredith, Un Jung Kang
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2015
Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and diseaseMaxime Cazorla, Un Jung Kang, Christoph Kellendonk
Pageof 10